Skip to the content
  • Home
  • Care Areas
        • Lung Cancer
        • Tuberculosis
        • Heart Failure
        • Neurocritical Care
        • Who We Help
  • Products
        • qXRAI for Chest X-rays
        • qERAI for Head CTs
        • qCT-LungAI for Chest CTs
        • qVHAI for Ultrasound
        • qMSKAI for Musculoskeletal X-rays
        • qTrackEnd-to-End Disease Management Platform
        • qRemoteStreamlining Patient-care Workflows for Early Intervention
        • How we deploy
        • Information Security and Medical Device Regulation
  • Our Impact
  • Evidence
  • Blog
  • About Us
    • Our Company
    • Newsroom
  • Contact Us
  • Region
    • UK
    • USA
    • Rest of the world
  • Try now
Qure AIQure AI
    • Home
    • Care Areas
          • Lung Cancer
          • Tuberculosis
          • Heart Failure
          • Neurocritical Care
          • Who We Help
    • Products
          • qXRAI for Chest X-rays
          • qERAI for Head CTs
          • qCT-LungAI for Chest CTs
          • qVHAI for Ultrasound
          • qMSKAI for Musculoskeletal X-rays
          • qTrackEnd-to-End Disease Management Platform
          • qRemoteStreamlining Patient-care Workflows for Early Intervention
          • How we deploy
          • Information Security and Medical Device Regulation
    • Our Impact
    • Evidence
    • Blog
    • About Us
      • Our Company
      • Newsroom
    • Contact Us
    • Region
      • UK
      • USA
      • Rest of the world
    • Try now
  • qER assists in reducing door-to-needle time and door-to-disposition time for patients by quick triage and treatment.
  • Using qQuant along with qER will additionally assist in quantifying the volume of intracranial structures and lesions rapidly and precisely.
  • Clinicians use this to track the progress of patients with hemorrhagic stroke, traumatic brain injury, or hydrocephalus and by researchers to develop new quantitative outcome measures. Clinicians also use these quantitative measurements to assist with determining the severity of the trauma, lesion, or underlying disease, or to assist with the comparison of multiple CT scans.

Featured in

The New York Times
MIT
Mashable
Health Policy Watch
GEN
Fortune
The Ken
Financial Times
Forbes
BBC
AstraZeneca
PBSP
Healius
ERICSSON
FHI 360
PATH
Blackford
vRad
Medica
LTE

Subscribe to our Newsletter

By clicking "subscribe" you consent to allow Qure.ai to store and process your information as per our privacy policy

Qure.ai Technologies Private limited

Qure.ai was founded in 2016. Our mission is to use artificial intelligence to make healthcare more accessible and affordable.

Follow Us

Products

  • qXR
  • qER
  • qCT-Lung
  • qVH
  • qMSK
  • qTrack
  • qRemote

Care Areas

  • Lung Cancer
  • Tuberculosis
  • Neurocritical Care
  • Who We Help

About

  • Our Company
  • Newsroom
  • Legal
  • Evidence
  • Our Impact
  • Blog
  • Contact Us

Privacy Policy

Legal Disclaimer

Information Security and Medical Device Regulation

CIN U74999MH2016PTC283891   |   © 2023 Qure.ai